Ribonuclease S Backbone Photoswitch
A R T I C L E S
between the CR and the CR′ atom by approximately 0.8 Å, and
versions (in the case of the recombination of modified S-peptides
18,19
14,31-34
the cis/trans ratio increases in the photostationary state.
This
with S-protein, the term RNase S’ is also in use).
We
isomer-specific chain displacement, in some proteins, propagates
into the distal part of the molecule.20 Unfortunately, the
wavelength range (<220 nm) of peptide absorbance, which must
be used for photoswitching, is not compatible with the photo-
chemical stability of proteins. In addition, fast re-equilibration
rates prevent the photoinduced cis population from applying
isomer-specific effects on a coupled reaction. We have been
developing a new approach to the peptide bond as a photore-
sponsive element of a protein that utilizes features of the near-
present results herein that suggest that backbone peptide bond
thioxylation located in the N-terminal region of the S-peptide
provides a reversible on/off photoswitch for the enzymatic
activity of RNase S.
4
We provide evidence that the incorporation of the trans Ala -
5
ψ[CS-NH]-Ala - segment into the S-peptide chain does not
4
5
impair the formation of the noncovalent (Ala -ψ[CS-NH]-Ala )
4
S-peptide/S-protein complex (ψ[CS-NH] -RNase S) and its
hydrolytic activity against cytidine 2′,3′-cyclic monophosphate
4
isosteric thioxopeptide bond (sC(dS)sNRs; R ) H, alkyl)
(cCMP). Irradiation of a ψ[CS-NH] -RNase S sample resulted
substitution.2
1-23
The process of photoisomerization of short
in a markedly increased nonequilibrium population of cis ψ-
4
thioxopeptides is completed within the picosecond time scale
[CS-NH] -RNase S that retained less than 1% cCMP cleaving
at a high quantum yield and does not exhibit a more prolonged
activity. The data of this study are indicative of a major chemical
change in the active site due to a predefined one-bond
phototrigger at a remote site.
reaction time for a longer peptide chain.2
4,25
Biologically, the
O/S exchange causes minor effects as long as a bioreaction does
not directly involve the respective amide carbonyl group. In
particular, it does not greatly affect secondary structure forma-
tion, and the bioactivity of the thioxopeptide derivative of
Experimental Section
General Considerations. All chemicals and reagents were purchased
with the highest purity commercially available (Fluka, Merck, Aldrich,
Sigma, Bachem, Novabiochem, Advanced ChemTech). The S-protein
(Grade XII) was purchased from Sigma. Peptide synthesis was
performed using a Syro II multiple peptide synthesizer (MultiSynTech,
Germany). Analytical HPLC was performed using solvent gradients
of B (ACN, 0.1% TFA) in A (H O, 0.1%TFA) on a Pharmacia LKB
2
HPLC system in combination with the peak integration software “PC
Integration Pack” (Kontron Instruments) and a LiChroCART 125-4 RP
ligands was found to be similar to that of the oxopeptide
congener.2
6-29
However, the lack of methods is evident for the
site-specific thioxylation of a mature polypeptide chain and the
chemical synthesis of an enzyme thioxylated at a predefined
position. In addition, classical strategies of chemical ligation,
which are normally used for synthesis of site-specific modified
polypeptides, are not suitable because the presence of thioxo-
peptide bonds is not compatible with the subsequent synthesis
of the thioester moiety which is necessary for the ligation
procedure.
One way to reconcile the latter drawback would be for a
protein which constitutes a bioactive molecule by noncovalently
recruiting an oligopeptide. In this case, the oligopeptide can be
prepared in the form of a mono- or polythioxylated molecule.
We were tempted to utilize RNase S to prepare an enzymati-
cally active protein containing a single thioxopeptide bond.
RNase S is composed of two RNase A fragments obtained by
subtilisin cleveage, the S-peptide (consisting of residues 1 to
8
(5 µm) column (Merck). Detection was performed at 220 nm, and
the solvent flow rate was 1 mL/min. Preparative HPLC was performed
on a Hibar RT 250-25 LiChrosorb RP-select B (7 µM) column using
an HPLC system from SYKAM (Germany). Concentrations of the
4
S-protein, S-peptide, and ψ[CS-NH] -S-peptide were determined using
-
1
-1
-1
the extinction coefficients ꢀ ) 9560 M cm , ꢀ257.5 ) 195 M
2
80
-1
-
1
-1
cm , and ꢀ266 ) 12 000 M cm , respectively.
Peptide Synthesis. Whereas the S-peptide was synthesized using a
standard protocol of solid-phase peptide synthesis, a special protocol
4
was used for the ψ[CS-NH] -S-peptide and Ac-Ala-ψ[CS-NH]-Phe-
NH
as described elsewhere.35 Peptides were purified by preparative
2
HPLC.
20), and the S-protein (consisting of residues 21 to 124) that
+
Ac-Ala-ψ[CS-NH]-Phe-NH
H ] found m/z ) 294.0; t
2
: [M + H ] calcd m/z ) 294.1; [M
constitute the active enzyme after mixing both components in
solution.30 It is well-known that RNase S dissociates and
associates in a pH-dependent manner allowing the substitution
of the natural S-peptide of RNase S by chemically modified
+
+
R
, 19.8 min (10-25% B in 30 min).
+
+
S-peptide: [M + H ] calcd m/z ) 2148.1; [M + H ] found m/z )
4
2
148.4; t
R
+
, 18.85 min (5-35% B in 30 min). ψ[CS-NH] -S-peptide:
+
[M + H ] calcd m/z ) 2164.1; [M+H ] found m/z ) 2164.1; t
R
, 18.86
min (5-35% B in 30 min).
(
18) Tsukahara, T.; Ishiura, S.; Sugita, H. Int. J. Biochem. 1991, 23, 79-83.
19) Wang, Y.; Purrello, R.; Spiro, T. G. J. Am. Chem. Soc. 1989, 111, 8274-
Isothermal Titration Calorimetry. Calorimetric experiments were
performed using a VP-ITC titration calorimeter (MicroCal, Inc,
Northampton, MA) at 25 °C. All solutions were degassed under vacuum
prior use. Solutions of the respective S-peptide derivative and S-protein
were dialyzed against 50 mM sodium acetate buffer (pH 6.0, 100 mM
NaCl). The volume of the protein solution (50 µM) in the sample cell
was 1.4 mL. The injection syringe was filled with 300 µL solution of
the respective S-peptide derivative (200 µM). Each titration experiment
consisted of a single 1 µL injection followed by 16 identical 5 µL
injections of the peptide solution.
(
8
276.
(
20) Reimer, U.; Fischer, G. Biophys. Chem. 2002, 96, 203-212.
21) Zhao, J.; Wildemann, D.; Jakob, M.; Vargas, C.; Schiene-Fischer, C. Chem.
Commun. 2003, 22, 2810-2811.
(
(
22) Frank, R.; Jakob, M.; Thunecke, F.; Fischer, G.; Schutkowski, M. Angew.
Chem. 2000, 112, 1163-1165; Angew. Chem., Int. Ed. 2000, 39, 1120-
1
122.
(
23) Zhao, J.; Micheau, J. C; Vargas, C.; Schiene-Fischer, C. Chem.sEur. J.
2
004, 10, 6093-6101.
(
24) Helbing, J.; Bregy, H.; Bredenbeck, J.; Pfister, R.; Hamm, P.; Huber, R.;
Wachtveitl, J.; De Vico, L.; Olivucci, M. J. Am. Chem. Soc. 2004, 126,
8
823-8834.
(
(
(
(
(
(
25) Satzger, H.; Root, C.; Gilch, P.; Zinth, W.; Wildemann, D.; Fischer, G. J.
Phys. Chem. B 2005, 109, 4770-4775.
26) Schutkowski, M.; Neubert, K.; Fischer, G. Eur. J. Biochem. 1994, 221,
(31) Richards, F. M.; Vithayathil, P. J. J. Biol. Chem. 1959, 234, 1459-1465.
(32) Wyckoff, H. W.; Tsernoglou, D.; Hanson, A. W.; Knox, J. R.; Lee, B.;
Richards, F. M. J. Biol. Chem. 1970, 245, 305-328.
(33) Liu, D.; Karanicolas, J.; Yu, C.; Zhang, Z.; Woolley, G. A. Biorg. Med.
Chem. Lett. 1997, 7, 2677-2680.
(34) Hamachi, I.; Hiraoka, T.; Yamada, Y.; Shinkai, S. Chem. Lett. 1998, 27,
537-538.
(35) Wildemann, D.; Drewello, M.; Fischer, G.; Schutkowski, M. Chem.
Commun. 1999, 18, 1809-1810.
4
55-461.
27) Kruszynski, M.; Kupryszewski, G.; Ragnarrson, U.; Alexandrova, M.;
Strbak, V.; Tonon, M. C.; Vaudry, H. Experentia 1985, 41, 1576-1577.
28) Angyal, R.; Strbak, V.; Alexandrova, M.; Kruszynski, M. Endocrinol. Exp.
1
985, 19, 213-219.
29) Alexandrova, M.; Strbak, V.; Herman, Z. S.; Stachura, Z.; Kruszynski, M.
Endocrinol. Exp. 1987, 21, 43-49.
30) Raines, R. T. Chem. ReV. 1998, 98, 1045-1066.
J. AM. CHEM. SOC.
9
VOL. 129, NO. 16, 2007 4911